Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
22 Results for "
PTHR1
" in MedChemExpress (MCE) Product Catalog:
Products (22)
22 Results for "PTHR1" in MCE Product Catalog:
3
3 Cited Publications
Synonyms: BA 058; BIM 44058
Research Areas:
3
Research Areas:
Target:
Research Areas:
PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor.
Target:
Research Areas:
AH3960 (compound 16c) is an antagonist of androgen receptor. AH3960 binds wild as well as T877 mutant type androgen receptors. AH3960 selectively inhibits T877 with an IC50 value of 0.82 μM. AH3960 also serves as an agonist of parathyroid hormone receptor-1 (PTHR1) [1] .
DS69910557 is a potent, selective and orally activehuman parathyroid hormone receptor 1 (hPTHR1) antagonist. DS69910557 has antagonistic activity for PTHR1 with an IC50 value of 0.08 μM. DS69910557 can be used for the research of hyperparathyroidism, hypercalcemia of malignancy and osteoporosis [1].
Target:
Research Areas:
DS08210767 is a highly potent, orally bioavailable PTHR1 antagonist with IC50 of 90 nM [1].
Cat. No.: HY-131206
CAS No.: 2460353-87-9
Target:
Research Areas:
DS37571084 is an orally active and potent antagonist of the parathyroid hormone type 1 receptor (PTHR1), with an IC50 value of 0.17 μM. DS37571084 can be used for the study of hyperparathyroidism [1].
Cat. No.: HY-120398
CAS No.: 1253919-92-4
Target:
Research Areas:
CH5447240 is an agonist for parathyroid hormone receptor 1 (PTHR1), that inhibits human PTHR1 with an EC50 of 12 μM. CH5447240 exhibits good metabolic stability in human liver microsomes. CH5447240 increases serum calcium levels in rats. CH5447240 can be used in research about hypoparathyroidism [1].
Cat. No.: HY-113918
Target:
Research Areas:
SW-106 is a selective antagonist of parathyroid hormone/parathyroid hormone-related peptide receptor (PPR) and PTHR1, with an IC50 value of 0.99 μM against PPR. SW-106 antagonizes cAMP responses. SW-106 can be used in the research of osteoporosis [1] .
Cat. No.: HY-P4856
CAS No.: 120298-73-9
Research Areas:
Cat. No.: HY-186200
CAS No.: 2458230-46-9
Target:
Research Areas:
PTHR1 antagonist 1 is a PTHR1 antagonist with an IC50 of 0.090 µM. PTHR1 antagonist 1 is applicable to the research of calcium metabolism disorders [1].
Cat. No.: HY-RS11395
Target:
Research Areas:
PTH1R Human Pre-designed siRNA Set A contains three designed siRNAs for PTH1R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-100856R
CAS No.: 1613373-33-3
Target:
Research Areas:
PCO371 (Standard) is the analytical standard of PCO371 (HY-100856). This product is intended for research and analytical applications. PCO371 is an orally active full agonist of parathyroid hormone receptor 1 (PTHR1), with no effect on PTH type 2 receptor.
Cat. No.: HY-RS17667
Target:
Research Areas:
Pth1r Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pth1r gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P1709
CAS No.: 141912-59-6
Category:
Target:
Cat. No.: HY-RS23068
Target:
Research Areas:
Pth Rat Pre-designed siRNA Set A contains three designed siRNAs for Pth gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
